217 related articles for article (PubMed ID: 3284692)
1. Use of cephalosporins with enhanced anti-anaerobic activity for treatment and prevention of anaerobic and mixed infections.
DiPiro JT; May JR
Clin Pharm; 1988 Apr; 7(4):285-302. PubMed ID: 3284692
[TBL] [Abstract][Full Text] [Related]
2. Third-generation cephalosporins: a critical evaluation.
Barriere SL; Flaherty JF
Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
[TBL] [Abstract][Full Text] [Related]
3. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.
Sweet RL; Ledger WJ
Obstet Gynecol; 1979 Aug; 54(2):193-8. PubMed ID: 460753
[TBL] [Abstract][Full Text] [Related]
4. Use of expanded spectrum cephalosporins for the treatment of obstetrical and gynecological infections.
Mercer LJ
Obstet Gynecol Surv; 1988 Sep; 43(9):569-75. PubMed ID: 3145476
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
[TBL] [Abstract][Full Text] [Related]
6. Role of cephamycins in obstetrics and gynecology.
Sweet RL
J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
8. Cefotetan: a second-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.
Gribble MJ
CMAJ; 1994 Sep; 151(5):537-42. PubMed ID: 8069799
[TBL] [Abstract][Full Text] [Related]
9. [Review of oral cephalosporins. Basis for a rational choice].
Forti IN
Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
[TBL] [Abstract][Full Text] [Related]
10. Infections in the female genital tract.
Gall SA
Compr Ther; 1983 Aug; 9(8):34-47. PubMed ID: 6413123
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolones and anaerobes.
Stein GE; Goldstein EJ
Clin Infect Dis; 2006 Jun; 42(11):1598-607. PubMed ID: 16652318
[TBL] [Abstract][Full Text] [Related]
12. [The importance of the use of antibiotics after surgical procedures on the abdominal cavity].
Rakovec S; Kovic M; Gubina M
Acta Chir Iugosl; 1982; 29(2):165-72. PubMed ID: 7168271
[TBL] [Abstract][Full Text] [Related]
13. Cefotaxime in the treatment of prophylaxis of surgical infections.
Wittmann DH; Jones RN; Malledant J; Privitera G
J Chemother; 1997 May; 9 Suppl 2():19-33. PubMed ID: 9248973
[TBL] [Abstract][Full Text] [Related]
14. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
Ginunas VJ; Canawati HN; Sapico FL
Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279
[TBL] [Abstract][Full Text] [Related]
15. The need for and choice of chemotherapy for anaerobic infections.
Selkon JB
Scand J Infect Dis Suppl; 1981; 26():19-23. PubMed ID: 6941452
[TBL] [Abstract][Full Text] [Related]
16. The role of anaerobic bacteria in human infections.
Zambrano D
Clin Ther; 1993; 15(2):244-60; discussion 215. PubMed ID: 8519035
[TBL] [Abstract][Full Text] [Related]
17. Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.
Neu HC
Pharmacotherapy; 1984; 4(2):47-60. PubMed ID: 6326062
[TBL] [Abstract][Full Text] [Related]
18. Cefmetazole sodium: pharmacology, pharmacokinetics, and clinical trials.
Schentag JJ
Pharmacotherapy; 1991; 11(1):2-19. PubMed ID: 2020609
[TBL] [Abstract][Full Text] [Related]
19. The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections.
Aldridge KE
Am J Surg; 1995 May; 169(5A Suppl):2S-7S. PubMed ID: 7755163
[TBL] [Abstract][Full Text] [Related]
20. The selection and use of cephalosporins: a review.
Klein NC; Cunha BA
Adv Ther; 1995; 12(2):83-101. PubMed ID: 10150326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
